WallStSmart
PHAT

Phathom Pharmaceuticals Inc

NASDAQ: PHAT · HEALTHCARE · BIOTECHNOLOGY

$11.20
-4.92% today

Updated 2026-04-30

Market cap
$935.69M
P/E ratio
—
P/S ratio
5.34x
EPS (TTM)
$-3.03
Dividend yield
—
52W range
$2 – $18
Volume
1.2M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Phathom Pharmaceuticals Inc (PHAT) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$682000.00$55.25M$175.11M
Revenue growth (YoY)——————+8001.5%+216.9%
Cost of revenue—$8000.00$300000.00$521000.00$620000.00$167000.00$7.97M$22.60M
Gross profit—$-8000.00$-300000.00$-521000.00$-620000.00$515000.00$47.28M$152.51M
Gross margin—————75.5%85.6%87.1%
R&D$20000.00$99.27M$98.15M$72.34M$71.44M$49.90M$34.08M$32.78M
SG&A$1.21M$6.94M$27.52M$62.74M$101.00M$117.93M$290.66M$279.72M
Operating income$-1.23M$-106.22M$-125.67M$-135.08M$-172.44M$-167.31M$-277.47M$-159.99M
Operating margin—————-24532.6%-502.2%-91.4%
EBITDA$-50000.00$-250.95M$-124.19M$-136.57M$-169.80M$-159.05M$-261.52M$-152.50M
EBITDA margin—————-23321.0%-473.3%-87.1%
EBIT$-1.27M$-250.95M$-124.49M$-137.09M$-170.42M$-159.62M$-262.32M$-153.13M
Interest expense$13000.00$4.18M$4.58M$6.79M$27.30M$41.97M$72.01M$68.11M
Income tax$13000.00$-45.39M$4.25M$4.21M$25.28M$41.78M——
Effective tax rate-1.0%17.8%-3.4%-3.0%-14.7%-26.1%0.0%0.0%
Net income$-1.29M$-209.74M$-129.07M$-143.88M$-197.72M$-201.59M$-334.33M$-221.25M
Net income growth (YoY)—-16184.5%+38.5%-11.5%-37.4%-2.0%-65.8%+33.8%
Profit margin—————-29558.9%-605.1%-126.3%